Resmed Inc.
RMD
Market Cap$27.87B
Close$
$182.81
2.9% upside
Current Fair Value
2.9% upsideUndervalued by 2.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $27.87 Billion |
|---|---|
| Enterprise Value | $28.89 Billion |
| Dividend Yield | $1.8724 (0.99%) |
| Earnings per Share | $6.03 |
| Beta | 1.05 |
| Outstanding Shares | 147,088,888 |
| Avg 30 Day Volume | 1,029,947 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 31.31 |
|---|---|
| PEG | -436.96 |
| Price to Sales | 5.92 |
| Price to Book Ratio | 5.92 |
| Enterprise Value to Revenue | 6.41 |
| Enterprise Value to EBIT | 23.07 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
ESG Score
No data
About Resmed Inc.
CEO: Michael Farrell